Utah Hematology Oncology Revenue and Competitors
Estimated Revenue & Valuation
- Utah Hematology Oncology's estimated annual revenue is currently $5.3M per year.
- Utah Hematology Oncology's estimated revenue per employee is $189,000
Employee Data
- Utah Hematology Oncology has 28 Employees.
- Utah Hematology Oncology grew their employee count by 4% last year.
Utah Hematology Oncology's People
Name | Title | Email/Phone |
---|
Utah Hematology Oncology Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $21.6M | 80 | 5% | N/A | N/A |
#2 | $219M | 649 | 7% | N/A | N/A |
#3 | $50.5M | 170 | N/A | N/A | N/A |
#4 | $52.5M | 181 | 14% | $47.5M | N/A |
#5 | $138.4M | 410 | 10% | N/A | N/A |
#6 | $17.3M | 71 | 6% | N/A | N/A |
#7 | $13188.8M | 34891 | 37% | N/A | N/A |
#8 | $7.8M | 38 | -28% | $3M | N/A |
#9 | $21.6M | 80 | N/A | N/A | N/A |
#10 | $12.9M | 53 | 20% | N/A | N/A |
What Is Utah Hematology Oncology?
Utah Hematology Oncology is Northern Utah’s largest and most experienced independent group of physicians and nurses dedicated to the treatment of cancer and blood-related disorders. Our focus is treating these diseases using the latest in drug and support therapies. In addition to the excellent care we provide our patients, they also receive the education and support they need to help them deal with the challenges represented by their illness. We strive to provide not only excellent, but also compassionate care to each patient. As we work together in the fight against these diseases, our patients become part of the UHO family. We are Your trusted partner in your CANCER fight.
keywords:N/AN/A
Total Funding
28
Number of Employees
$5.3M
Revenue (est)
4%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $5.7M | 28 | 0% | N/A |
#2 | N/A | 28 | 56% | N/A |
#3 | $3.5M | 28 | 4% | N/A |
#4 | $6.7M | 29 | 12% | N/A |
#5 | $5.9M | 29 | -17% | N/A |